Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. R. Wijsman

Publications

A planning study of proton therapy dose escalation for non-small cell lung cancer

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

Continuous and bilevel positive airway pressure may improve radiotherapy delivery in patients with intra-thoracic tumors

Estimating how contouring differences affect normal tissue complication probability modelling

O151 / #846 - First experience with in vivo range probing quality control procedure for moving targets treated with intensity-modulated proton therapy

Probability maps for deep learning-based head and neck tumor segmentation: Graphical User Interface design and test

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy

Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations

Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion

Read more